choline alphoscerate

DRUG2 trials

Sponsors

Azienda Ospedaliero-Universitaria Careggi, Samsung Medical Center

Conditions

Major DepressionVascular Cognitive Impairment

Phase 2

Choline Alphoscerate-Nimodipine in Vascular Cognitive Impairment

CompletedNCT03228498

Azienda Ospedaliero-Universitaria CareggiVascular Cognitive Impairment

Start: 2017-05-02End: 2019-07-09Updated: 2020-01-13

Unknown Phase

Clinical Effectiveness of Choline Alphoscerate for Older Adults With Major Depression and Subjective Memory Complaints

CompletedNCT05257902

Samsung Medical CenterMajor Depression

Start: 2022-08-19End: 2026-06-30Updated: 2026-07-27

Related Papers

Efficacy and Safety of the Association of Nimodipine and Choline Alphoscerate in the Treatment of Cognitive Impairment in Patients with Cerebral Small Vessel Disease. The CONIVaD Trial

Drugs & Aging2021-04-1516 citations

Association of nimodipine and choline alphoscerate in the treatment of cognitive impairment in patients with cerebral small vessel disease: study protocol for a randomized placebo-controlled trial-the CONIVaD trial.

2019-05-3013 citations